Autoimmune diseases and thalidomide. II. Adjuvant disease, experimental allergic encephalomyelitis and experimental allergic neuritis of the rat.
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D004195:Disease Models, Animal; D004341:Drug Evaluation; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D005620:Freund's Adjuvant / Q000009:adverse effects; D006099:Granuloma / Q000188:drug therapy; D006168:Guinea Pigs; D006967:Hypersensitivity / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D009161:Mycobacterium / Q000276:immunology; D009169:Mycobacterium tuberculosis / Q000276:immunology; D009443:Neuritis / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D051381:Rats; D013045:Species Specificity; D013792:Thalidomide / Q000627:therapeutic use*
D013792:Thalidomide; D005620:Freund's Adjuvant